It looks like you're using an Ad Blocker.

Please white-list or disable AboveTopSecret.com in your ad-blocking tool.

Thank you.

 

Some features of ATS will be disabled while you continue to use an ad-blocker.

 

High-priced drugs raising questions

page: 1
0

log in

join
share:

posted on Mar, 16 2008 @ 08:16 PM
link   

High-priced drugs raising questions


www.upi.com

NEW YORK, March 16 (UPI) -- Some researchers are questioning the ethics of prescribing higher-than-necessary doses of high-priced drugs in the United States.
..Some researchers say that for many patients as little as one-fourth of the standard dose is effective, and could save more than $200,000 a year per Gaucher patient. About 1,500 people in the United States take the drug, the newspaper said.
"It is economic malpractice to give a much higher dose of an expensive drug than is required," Dr. Ernest Beutler, an authority on Gaucher disease at the Scripps Research Institute, was quoted by the newspaper as saying.
(visit the link for the full news article)




posted on Mar, 16 2008 @ 08:16 PM
link   
To me this isn't anything new. Just another way for pharmas to make additional profit. Why give more of a drug if less will have the same effect?
Of course Genentech's executive says that the doses are for maximum effectiveness. So by that logic, the more you take and the quicker you take it, the sooner you will get better.
Yeah, sounds like a good treatment plan doesn't it?

www.upi.com
(visit the link for the full news article)



new topics
 
0

log in

join